Last Updated on 2 years by Publishing Team

25 November 2021

Public Advisory

COVID-19 Vaccination Registration for Fijian Residents Vaccinated Abroad

Individuals who are Fijian Citizens or Fiji Permit Holders and have received their COVID-19 vaccination in another country apart from Fiji, can now register their vaccination details in the Fijian Government Digital Vaccination Registry System.

An individual can register at https://vra.digitalfiji.gov.fj// under the international vaccination registration category. To register, an individual must have:

  • A valid vaccination reference number (if any dose of the COVID-19 vaccine was received in Fiji)
  • Birth Registration Number/Citizenship Number
  • A valid photo identification – Joint FNPF/FRCA, driver’s license, passport, student ID, or FNPF card.
  • A scanned copy of the valid vaccination card/certificate as proof of vaccination is the official document of the country where the individual was vaccinated.

For any queries, email: regvaxinternational@gmail.com

To learn more about registering into the International Vaccination Registry, go to:

The verification of the registration and an individual’s vaccination status will be completed within 3-5 days.

Registration Guideline

Explore More

Update on the roll out of the Moderna COVID-19

November 15, 2021 0 Comments 0 tags

Public Advisory: 14th November 2021 Update on the rollout of the Moderna COVID-19 vaccines for children aged 15-17 years old As of 14th November 2021, a total of 33,316 children

COVID-19 Booster Dose Intervals

March 25, 2022 0 Comments 0 tags

24th March 2022 Public Advisory COVID – 19 Booster dose intervals shortened to 3 months after 2nd dose. The Ministry of Health and Medical Services has updated its recommendation for

New analysis by Public Health England – Delta (B.1.617.2) Variant

July 19, 2021 0 Comments 0 tags

New analysis by Public Health England has shown that 2 doses of COVID-19 vaccines are highly effective against hospitalization from the Delta (B.1.617.2) variant. The analysis suggests that the Oxford-AstraZeneca